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The difﬁculty in successfully treating infections caused by methicillin-resistant Staphylococcus aureus (MRSA)
has led to them being referred to as highly virulent or pathogenic. In our study of one of the major healthcare-
associated MRSA (HA-MRSA) clones, we show that expression of the gene responsible for conferring
methicillin resistance (mecA) is also directly responsible for reducing the ability of HA-MRSA to secrete
cytolytic toxins. We show that resistance to methicillin induces changes in the cell wall, which affects the
bacteria’s agr quorum sensing system. This leads to reduced toxin expression and, as a consequence, reduced
virulence in a murine model of sepsis. This diminished capacity to cause infection may explain the inability of
HA-MRSA to move into the community and help us understand the recent emergence of community-associated
MRSA (CA-MRSA). CA-MRSA typically express less penicillin-binding protein 2a (encoded by mecA), allowing
them to maintain full virulence and succeed in the community environment.
Methicillin-resistant Staphylococcus aureus (MRSA) is
a major cause of nosocomial infections worldwide, with
factors such as exposure to broad-spectrum antibiotics,
presence of indwelling catheters, and recent surgery
leading to increased susceptibility to infection [1–3].
Genetic analyses of healthcare-associated MRSA (HA-
MRSA) have shown that certain clones have become
endemic in these environments, but these MRSA are
rarely found to cause infections in individuals with no
healthcare contact (ie, in the community environment
[2, 3]). The recent emergence of community-associated
MRSA (CA-MRSA), which can cause infections outside
healthcaresettings among otherwise healthy individuals,
is a growing concern [2, 3]. Comparisons of HA-MRSA
with CA-MRSA have revealed genetic differences be-
tween these 2 groups [3–6] but none that explain why
HA-MRSA is restricted to healthcare environments
when CA-MRSA is not.
Resistance to methicillin and oxacillin (the clinically
used derivative of methicillin) is conferred by the ac-
quisition of a mobile genetic element: staphylococcal
chromosomal cassette mec (SCCmec)[ 4]. The elements
vary in size (20–70 kb) and genetic content, but they all
contain the mecA gene, which encodes an alternative
penicillin-binding protein (PBP), PBP2a [5, 6]. Genetic
analyses of HA-MRSA and CA-MRSA have shown that
HA-MRSA tends to carry the large types I, II, and III
SCCmec elements, whereas CA-MRSA tends to carry the
smaller type IV and V elements [5, 6]. Penicillin-binding
proteins are membrane-bound enzymes that catalyze the
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major structural component of the bacterial cell wall [6].
b-Lactam antibiotics irreversibly acylate the catalytic serine within
t h et r a n s p e p t i d a s ea c t i v es i t eo fP B P s[ 7]. This impairs effective
peptide cross-linking, destabilizing the cell wall and resulting in
bacterial lysis. Methicillin-resistant S. aureus strains are resistant
because PBP2a has a lower afﬁnity for b-lactam antibiotics, en-
abling it to continue its catalytic activity even in the presence of
the antibiotic [7]. However, the expression of PBP2a alone is
often not sufﬁcient to confer resistance; many other contributing
cell wall and membrane proteins have been identiﬁed [8–10].
Studies comparing the relative virulence of MRSA types and
methicillin-susceptible S. aureus (MSSA) suggest a contra-
dictory virulence hierarchy: HA-MRSA . MSSA [11–13];
CA-MRSA . HA-MRSA [14, 15]a n dM S S A5 CA-MRSA
[16, 17]. This illustrates the need for further characterization
of their relative virulence. The environments in which these
infections occur will select for the most successful pathogen.
An understanding of how (and if) the relative virulence of
these strains vary depending on environment will inform us of
strategies to employ to control and contain their success.
We previously reported that MRSA strains containing the
hospital-associated type II SCCmec element were less toxic
(as measured by their ability to lyse T cells) than their
antibiotic-sensitive relatives, whereas the toxicity of strains
carrying the smaller community-associated type IV elements
were not affected [18, 19]. Here we demonstrate that the
reduced toxicity of HA-MRSA is a direct result of mecA
expression, mediated by interference with the S. aureus acces-
sory gene regulator (agr) quorum sensing system. We found
that this MRSA was impaired in its ability to respond to the agr
auto-inducing peptide (AIP), but removal of the cell wall re-
stored this ability. This suggests that the expression of mecA and
either its potential to subtly affect peptidoglycan structure or its
interaction with other cell wall–associated proteins prevent the
AIP from being detected. This results in an unresponsive agr
system and subsequent low-level toxicity. To compare the vir-
ulence of MRSA to its isogenic MSSA strain, we used a murine
infection model and found that the expression of the antibiotic-
resistant gene mecA reduced the virulence of MRSA. As a direct
consequence of its high level of antibiotic resistance, HA-MRSA
is impaired in its ability to cause infection, which can explain its
inability to cause infection in community settings, where anti-
biotic usage and the prevalence of susceptible patients are low.
MATERIALS AND METHODS
Strains and Plasmids Used in This Study
Construction of mecA Mutation in BH1CC
The mecA gene was ampliﬁed by polymerase chain reaction
(PCR) from BH1CC using Phusion high-ﬁdelity DNA poly-
merase (NEB) and cloned into PCR-Blunt II-TOPO plasmid
(Invitrogen) and inactivated by cloning the tetracycline re-
sistance gene from pBlue::tet into its internal MfeI-NheI sites
(Table 1). This was subcloned into a temperature-sensitive
Escherichia coli–Staphylococcus shuttle vector pBT2-bga and
transformed by electroporation into S. aureus RN4220 and
ﬁnally into S. aureus MRSA BH1CC. Allelic replacement of
the temperature-sensitive pSAmecA8 in BH1CC was achi-
eved following repeated growth (3 subcultures) at 42Cf o r
24 hours without antibiotic selection, followed by selection
of tetracycline-resistant (10 lg/mL) colonies on brain-heart
infusion (BHI) agar plates. The colonies were then screened
for chloramphenicol sensitivity to conﬁrm plasmid loss, and
PCR analysis was used to verify the presence of the mecA::Tcr
allele on the chromosome. The mutation was conﬁrmed
by Western immunoblot analysis of PBP2a expression and
reduced oxacillin minimum inhibitory concentration (MIC;
data not shown).
Cloning and Expression of mecA and Construction of the
S403A Mutation
ControlledexpressionofmecAwasachieved using a tetracycline-
inducible system previously described [27]. The mecA coding
region was ampliﬁed by PCR using the primers TTTGGTAC-
CAGTCTTATATAAGGAGGATATTGATG and AAAGAGCT-
CCGTTATCGCTGAAATTAC and cloned into plasmid pRMC2
to make pmecA. This was electroporated into S. aureus RN4220
and subsequently into S. aureus BH1CC DSCCmec to com-
plement the mecA mutation. A serine-to-alanine substitution at
position 403 (critical catalytic codon [7]) was made in pmecA
using the primers GTGAAGTTGTAATCTGGAACTTGTT-
GAGC and CAGGTGCAACTCAAAAAATATTAACAGCAATG
in an inverse PCR approach, followed by ligation and trans-
formation into DH5a to make pS403A. Mutation was veriﬁed
by sequencing and reduced MIC to oxacillin, and the plasmid
was transformed into BH1CCDSCCmec, as described above.
Construction of Oxacillin Resistant 8325-4
Although tetracycline-induced expression of mecA from the
plasmid pmecA was sufﬁcient to restore oxacillin resistance to
BH1CCDSCCmec, it was not sufﬁcient to confer oxacillin re-
sistance to the MSSA strain 8325-4 (determined using Etest
strips [Biome ´rieux]). Instead the mecA gene was recloned under
the control of its own promoter into the shuttle vector pRB474
[22]. The mecA gene was ampliﬁed using primers SAmecA3
(TGACGATTCCAATGACGAAC) and SAmecA4 (GCATCTG-
GCATGCATACACT) and cloned initially into pCR-Blunt
II-TOPO (pSAmecA5) and subsequently on an EcoRI frag-
ment into pRB474 to create pmecA2. The MSSA strain 8325-4
was transformed with pmecA2, and homogeneously resistant
8325-4colonieswereselectedonBHIagarcontaining 100lg/mL
of oxacillin.
T-Cell Toxicity Assays
T-cell toxicity assays were performed as described previously
[18, 30]. Where relevant, 200 ng/mL anhydrous tetracycline was
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promoter pmecA and pS403A.
Growth Curves and RNAIII::GFP Readings
BHI broth (100 mL in 250-mL conical ﬂasks) was inoculated
with 100 lL of overnight cultures (grown in BHI at 37C,
shaking at 180 rpm). Cultures were grown at 37C, 180 rpm;
samples were taken every hour; and optical density of 600 nm
(OD600) was measured. Fluorescence intensity of samples was
measured using a FARcyte XFLURO4 V 4.50 plate reader be-
tween 485 nm and 535 nm.
RNA Isolation
BHIbroth(100mLin250-mLconicalﬂask)wasinoculatedwith
100 lL of overnight cultures and grown at 37C, 180 rpm. RNA
was isolated after 20 hours of growth using the Qiagen RNeasy
Midi Kit according to the manufacturer’s instructions with an
addition of 0.2 lg/lL of lysostaphin to the lysis step. RNA
quality and concentration were determined using the Bio-Rad
Experion RNA Analysis System.
Reverse Transcription and qRT-PCR
Complementary DNA (cDNA) was generated from messen-
ger RNA (mRNA) using the NEB First Strand Synthesis kit
in accordance with the manufacturer’s instructions using
random hexamers. The following gyrB and RNAIII primers
were useddRNA III forward: GAAGGAGTGATTTCAATG
GCACAAG; and reverse: GAAAGTAATTAATTATTCATCT
TATTTTTTAGTGAATTTG; gyrB forward: CCAGGTAAAT
Table 1. Strains and Plasmids Used in the Study
Strain Relevant Characteristics Reference
BH1CC Clinical isolate, type II MRSA CC8 [19]
BH1CCDSCCmec SCCmec excised from the chromosome via the recombinase activity
of the ccrA and ccrB genes encoded on the plasmid pSR2
[18]
BH1CCDmecA Construced via allele replacement to produce a DmecA::Tc
r mutant.
Tetracycline resistant
This study
BH1CCDSCCmec 1pmecA SCCmec mutation complemented with the mecA gene under
tetracycline-inducible control
This study
BH1CC DSCCmec 1pS403A As above with a serine to alanine substitution at position 403 in
the mecA gene. Serine residue responsible for cross-linkage
of PBP2a [7]
This study
RN4220 Restriction negative derivative of 8325-4 [20]
RN6390B agr positive control strain [21]
RN6911 agr negative derivative of RN6390B [22]
8325-4 Laboratory oxacillin/methicillin-sensitive Staphylococcus aureus
strains
[23]
8325-4 (pmecA2) Oxacillin resistant This study
MRSA252 MRSA (type II SCCmec)[ 24]
MRSA45 MRSA (type II SCCmec [24]
MRSA137 MRSA (type II SCCmec)[ 24]
MRSA281 MRSA (type II SCCmec)[ 24]
MRSA370 MRSA (type II SCCmec)[ 24]
MRSA504 MRSA (type II SCCmec)[ 24]
MRSA858 MRSA (type II SCCmec)[ 24]
MRSA720 MRSA (type IV SCCmec)[ 24]
90/10685 MRSA (type IV SCCmec)[ 25]
BTN170 MRSA (type IV SCCmec)[ 26]
BTN1626 MRSA (type IV SCCmec)[ 26]
SwedenAO MRSA (type IV SCCmec)[ 25]
Plasmids
pRMC2 Plasmid containing a tetracycline-inducible promoter system [27]
pmecA pRMC2 plasmid containing the mecA gene under the control of a
tetracycline-inducible promoter
This study
pS403A pRMC2 plasmid containing the mecA gene under the control of a
tetracycline-inducible promoter with a serine-to-alanine substitution
at position 403
This study
pRB474 Escherichia coli2Staphylococcus shuttle vector [28]
pmecA2 pRB474 containing the mecA under the control of its own promoter This study
pRNAIII::GFP Plasmid containing a fusion of RNA III to GFP [29]
Abbreviations: GFP, green ﬂuorescent protein; MRSA, methicillin-resistant Staphylococcus aureus.
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AG. Standard curves were performed for each primer set on
serial dilutions of cDNA to determine primer efﬁciency. The
quantitative reverse-transcriptase PCR (qRT-PCR) reactions
w e r es e tu pa sf o l l o w s :5lLc D N A ,7 . 5lLo fS Y B Rr e a g e n t ,
0.5 lLf o r w a r dp r i m e r( 1 0lM), 0.5 lL reverse primer
(10 lM), and RNase-free water to a total volume of 15 lL.
Cycle threshold values were subsequently determined for 3 bi-
ological repeats in triplicate. For each reaction, the ratio of
RNAIII and gyrB transcript number was calculated as follows:
2
(Ct gyrB 2 Ct RNAIII).
AIP Induction Assay
Synthetic AIP-1 [31] was reconstituted in dimethyl sulfoxide
(DMSO) to a concentration of 10 mM. Bacterial strains were
grown overnight in BHI and used to inoculate 5 mL BHI
(10 lg/mL of chloramphenicol) in 30-mL tubes. The bacteria
were grown for 2–3 hours to an OD600 of 0.2. The bacteria
were washed and resuspended in 30% rafﬁnose and 10%
BHI. This medium was sufﬁcient to maintain spheroplast
integrity while providing sufﬁcient nutrients for RNAIII
transcription and GFP translation to take place. To each
strain, combination of AIP-1, DMSO and lysostaphin
(0.1 lg/mL) were added and incubated at 37C for 3 hours.
RNAIII::GFP expression was measured as described above
every 30 minutes.
Animal Experiment
Casein casein yeast broth (10 mL in 50-mL ﬂask) was in-
oculated with 200 lL of overnight cultures and grown at 37C,
225 rpm to exponential phase (OD600 5 0.8), harvested by
centrifugation, washed, and resuspended in sterile phosphate-
buffered saline to the desired infection dose. Bacterial density
in the inoculum was veriﬁed by culturing serial dilutions on
tryptic soy agar plates.
For the low inoculum infections, the mice were injected in-
travenously with 3–5 3 10
6 S. aureus in a volume of 500 lL.
Mice were weighed daily for 2 weeks, and weight change dif-
ferences were analyzed for statistical differences using the Stu-
dent t test. For the high inoculum infections, the mice were
injected intravenously with 1–2 3 10
7 S. aureus in a volume of
500 lL. Mortality was assessed up to 7 days after infection;
statistical differences between groups were analyzed using the
Student t test. All surviving mice were euthanized at day 7 after
inoculation.
Criteria for determining morbidity/sickness in mice included
hunched posture, decreased activity, rufﬂed fur, and labored
breathing. All animal experiments conformed to the National
Institutes of Health guidelines and were approved by the In-
stitutional Animal Care Use Committee at the Texas A&M
Health Science Center Institute of Bioscience and Technology.
Measurement of MIC to Oxacillin
Measurement of MIC to oxacillin was performed in accordance
with the Clinical and Laboratory Standards Institute guidelines
using Etest strips from Biome ´rieux on Mueller Hinton agar
containing 2% sodium chloride.
Analysis of PBP2a Expression
Total cell protein preparations were made from overnight cul-
tures of bacteria grown in BHI. The cells were harvested and
lysed in water containing 10 lg/mL lysostaphin, 4 units of
DNAase, 4 units of RNAase, and 0.05 mg/mL sodium dodecyl
sulphate by incubating at 37C for 1 hour. Insoluble material
was removed bycentrifugation,and proteinconcentrationswere
determined by Bradford assay. Western blots were performed
using anti-PBP2a antibodies (Abnova) and ProteinG-HRP
(Sigma) and visualized using a colorimetric detection system
(4CN, Bio-Rad). Band intensity was quantiﬁed using the Im-
ageJ software (http://rsbweb.nih.gov/ij/) and is expressed
relative to the positive control run on each gel.
RESULTS
Expression of mecA Reduces Toxicity
In previous work, we reported that clinical MRSA isolates
(n 5 24) carrying the type II SCCmec element were less toxic
than clonally matched MSSA strains [30]. We subsequently
demonstrated that the carriage of the type II element was di-
rectly responsible for this by deleting it from the hospital-
acquired MRSA strain BH1CC and showing that it restored
cytolytic activity to MSSA levels [18]. While attempting to
identify the gene(s) on this SCCmec element responsible for this
phenotype, we found that deletion of the mecA gene alone was
sufﬁcient to restore toxicity (Figure 1A). Expression of the mecA
gene from a tetracycline-inducible promoter (pmecA)i nt h e
BH1CCDSCCmec strain reduced toxicity to wild-type MRSA
levels in a dose-dependent manner (Figure1A). (The abundance
of antibiotic resistance markers in the BH1CCDmecA mutant
prevented us from complementing mecA in this strain.) By
contrast, expression of a mutant of mecAencoding a catalytically
inactive PBP2a (expressed on pS403A [7]) failed to reduce
toxicity. This effect was additionally veriﬁed by expressing ox-
acillinresistanceinanMSSAstrain(8325-4),inwhichthe ability
of the resistant strain to lyse T cells was reduced (Figure 1B).
Expression of the agr-Regulated b-Toxin Is Affected by the
Presence of mecA
The agr quorum sensing system is a major regulator of toxin
expression in S. aureus [20], and several studies have reported
ah i g hi n c i d e n c eo fagr dysfunction among clinical HA-MRSA
strains based on their hemolytic proﬁles [30, 32]. The immor-
talized T cells used in this assay are sensitive to b-toxin [30],
which is regulated by agr [33]. The functional expression of
b-toxin by BH1CC, BH1CCDSCCmec, and BH1CCDmecA was
determined by hot-cold lysis of sheep blood [34], in which we
found the expression of b-toxin to be lower in the MRSA strain
BH1CC compared with its MSSA mutants (data not shown).
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effect than deletion of mecA alone, perhaps as a consequence
of the additional regulatory elements found on these SCCmec
elements[35, 36]. To verify that the observed effecton toxicity
was not a result of adventitious mutations within the agr
locus [37, 38], we sequenced it in BH1CC, BH1CCDSCCmec,
and BH1CCDmec. We found them to be identical to each
other and to that of strain Newman, which has a functional
agr system.
Induction of the agr Quorum Sensing System Is Affected by the
Presence of mecA
Wehave previously shownthatT cells are lesssusceptible tolysis
when incubated with the supernatant of an agr mutant [30]. To
examine whether altered agr activity contributed to the reduced
MRSA toxicity, we introduced a plasmid containing the RNAIII
promoter fused to the green ﬂuorescent protein (RNAIII::GFP
[29]) into BH1CC, BH1CCDSCCmec, BH1CCDmecA, and iso-
genic control strains RN6390B (agr
1 [21]) and RN6119 (agr
2
[22]). No differences in the ability of these strains to grow was
detected by measuring the OD600 over a growth curve (data not
shown); however, their ability to induce expression of RNAIII
was affected by the presence of the mecA gene (Figure 2). The
MRSA strain BH1CC and the agr
2 strain RN6119 did not dis-
play the typical stationary phase induction of RNAIII as dis-
played by the control agr
1 strain RN6390B. Deletion of the
SCCmec element or the mecA gene alone restored the stationary
phase induction of RNAIII. These results were veriﬁed by qRT-
PCR, in which the expression of RNAIII (relative to gyrB)w a s
5.8-fold higher in BH1CCDmecA than in wild-type MRSA
strain BH1CC (P 5 .005). From this we conclude that the
presence of the mecA gene inhibits the expression of RNAIII,
the effector molecule of the agr quorum sensing system.
Figure 1. The expression of the mecA gene lowers toxicity. Survival of
T cells after exposure to bacterial culture supernatants. Open circles
represent individual data points, closed circles represent the mean of the
data sets, the error bars represent the 95% confidence intervals and the
asterisks indicate differences with p values of less than .05. A, The
BH1CC strain is less toxic than BH1CCDSCCmec and BH1CCDmecA
(P 5 .002 and .002, respectively), demonstrating that the presence of
the mecA gene is responsible for the reduced toxicity. Complemen-
tation of BH1CCDSCCmec with a plasmid expressing the mecA gene
from a tetracycline-inducible promoter (pmecA) reduces the toxicity of
the strain in a dose-dependent manner (P 5 .02), whereas the
catalytically inactive version of mecA (pS403A) does not affect toxicity
(P 5 .63). B, T-cell survival following exposure to the supernatent of
S. aureus strain 8325-4 containing the empty plasmid vector (pRB474),
and expressing mecA(pmecA2) (p, .001).
Figure 2. The presence of the mecA gene prevents stationary phase
activation of RNAIII. The activity of the RNAIII promoter (fused to green
fluorescent protein) over 12 hours of growth for the following strains:
RN6390B (agr
1, closed triangles), RN6119 (agr
2, open triangles), BH1CC
(methicillin-resistant Staphylococcus aureus [MRSA], closed squares),
BH1CCDSCCmec (isogenic methicillin-susceptible S. aureus [MSSA],
open squares), and BH1CCDmecA (isogenic MSSA, gray squares). The
data show that BH1CC and RN6119 did not display the typical stationary
phase RNAIII induction, whereas deletion of the SCCmec element or mecA
alone restored this induction to levels similar to the control agr
1 strain
RN6390B. The data is presented as the mean of five independent
replicates, and the error bars are the 95% confidence intervals.
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agr AIP
To switch on toxin expression, a threshold density of the se-
creted agr AIP is sensed, and this triggers expression of the agr
regulatory effector-molecule RNAIII [21, 22]. That the MRSA
strain BH1CC is unable to switch on the agr quorum sensing
system, despite reaching high cell densities, suggested that it
may be unable to respond to extracellular AIP. To test this,
we developed an AIP induction assay by growing cells to
early exponential phase in which RNAIII is not expressed.
Synthetic AIP was added to these cells, and the induction of
RNAIII::GFP expression was assayed. A gradual induction of
RNAIII was observed in the control strain RN6390B (agr
1)
over 3 hours after addition of synthetic AIP (Figure 3A).
When compared with the control agr
1 strain, the MRSA
strain BH1CC expressed lower levels of RNAIII in the pres-
ence of the AIP (P , .001), but deletion of the entire SCCmec
element (BH1CCDSCCmec)o rmecA alone (BH1CCDmecA)
restored the ability of this strain to express RNAIII to control
levels (P . .05) (Figure 3B). This demonstrates that mecA
affects the ability of the MRSA strain to respond to extracel-
lular AIP.
MecA-encoded PBP2a is a membrane protein that directly
affects the cell wall and requires additional cell wall and
membrane proteins to be expressed to confer oxacillin re-
sistance [8–10]. We hypothesized that cell wall changes as-
sociated with oxacillin resistance may affect AIP detection.
To test this, we produced spheroplasts by digesting the cell
wall of these strains in an osmotic solution of rafﬁnose that
maintained membrane integrity. The AIP induction assay was
repeated and, as shown in Figure 3B, digestion of the cell wall
from BH1CCenabled it to respond to AIP.Thesedataindicate
that expression of mecA, either directly or indirectly through
its auxillary proteins [8–10], results in cell wall changes that
interfere with the ability of the agr system to detect or respond
to the AIP. This may be a consequence of decreased perme-
ability associated with subtle changes to the structure of the
peptidoglycan [39, 40] in the cell wall associated with meth-
icillin resistance, or it may be that these changes somehow
interfere with the activity of AgrC, the systems membrane
receptor protein.
The mecA Gene on the Type II SCCmec Element Reduces
Virulence
To directly compare the virulence of an isogenic set of MRSA
and MSSA strains, and to verify that the effect of the mecA gene
on the toxicity of a strain is not an in vitro phenomenon, we
compared BH1CC, BH1CCDSCCmec, and BH1CCDmecA in
a murine sepsis model. The relative weight loss of the mice
infected with these strains can be seen in Figure 4A,a n dt h e
percentage survival of the mice can be seen in Figure 4B.T h e s e
data show a signiﬁcant difference in morbidity and mortality
between these isogenic MRSA and MSSA strains, demonstrating
that the presence of the mecA gene signiﬁcantly reduces the
virulence of this MRSA strain.
MRSA Strains Carrying the Type IV SCCmec Element Express
Less PBP2a and Are More Toxic Than Those Carrying the Type II
Element
We previously reported that MRSA strains carrying the
community-associated type IV SCCmec element were as
toxic as MSSA strains [18, 30]. We hypothesized that because
Figure 3. The methicillin-resistant Staphylococcus aureus (MRSA) cell wall prevents the detection of the agr quorum sensing system auto-inducing
peptide (AIP). A, Induction of RNAIII expression by the agr
1 strain RN6390B as measured by green fluorescent protein fluorescence over time in response
to either synthetic AIP (squares) or dimethyl sulfoxide (solvent control, circles). B, The ability of strains to respond to AIP is represented as the percentage
RNAIII expression relative to the agr
1 control strain RN6390B 180 minutes after the addition of AIP. Whole cells of the MRSA strain BH1CC displayed
significantly lower levels of RNAIII expression compared with the agr
1 strain in response to the AIP, whereas the deletion of the entire SCCmec element
or just mecA alone restored the ability of the strain to respond. The removal of the cell wall by digestion with lysostaphin (spheroplasts) enabled the
MRSA strainBH1CC to respond tothe AIP (P 5 .0002) buthad noeffectonthe other strains. Theasterisksindicate statisticallysignificant differences (, .05).
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MRSA [41], they may express lower levels of PBP2a and, as
a consequence, may be able to fully express toxins. To test
this, we compared the toxicity, the MIC of oxacillin, and the
expression of PBP2a of a set of clinical MRSA strains car-
rying either the hospital-associated type II or the commu-
nity-associated type IV SCCmec element. As presented in
Table 2 and Figure 5, those carrying the type II SCCmec
element all had an MIC of greater than 256 lg/mL to oxa-
cillin, a T-cell survival rate between 28.6% and 88%, and
a relatively high level of expression of PBP2a, whereas
those carrying the type IV SCCmec element had lower
MICs (12–32 lg/mL) and higher toxicity (T-cell survival,
0%–13%) and expressed less PBP2a (on average 13-fold
less). This lower level of PBP2a expression may explain why
MRSA strains carrying the type IV SCCmec elements, al-
though oxacillin resistant, are more toxic than those carrying
type II elements.
DISCUSSION
For HA-MRSA, the evolution of resistance to oxacillin has
a clear selective advantage in environments where antibiotic
usage is high. The secondary effect of a decrease in virulence
associated with resistance has not undermined its ability to be-
come a successful nosocomial pathogen. It is likely that the
high prevalence of susceptible patients in these environments
and an additional transmission route via healthcare workers,
compensate for reduced virulence. The reduced toxicity
is, however, a likely explanation for why these HA-MRSA
Figure 4. The mecA gene reduces virulence in a murine bacteremia model. Mice were inoculated intravenously with either the methicillin-resistant
Staphylococcus aureus (MRSA) strain BH1CC (squares) or the isogenic methicillin-susceptible S. aureus (MSSA) strains DSCCmec (triangles) or DmecA
(circles). A, Weight change in mice following intravenous infection. Balb/c mice (7–9 animals per group) were intravenously infected with 3–5 3 10
6
S. aureus in a volume of 500 lL and weighed before and after infection. *P , .02, BH1CC vs BH1CC DSCCmec or DmecA;* * P , .02, BH1CC vs
BH1CCDmecA (unpaired t test with Welch correction). B, Percentage of survival following intravenous injection with S. aureus. Balb/c mice (16–18
animals per group) were injected intravenously with 1–2 3 10
7 S. aureus in a volume of 500 lL. Mortality was assessed up to 7 days after infection. The
percentage of survival of mice infected with BH1CC was significantly different compared with those infected with BH1CCDSCCmec and BH1CCDmecA
(*P ,.0008, **P ,.00004; Student t test).
Table 2. Phenotypic Characteristics of Methicillin-Resistant
Staphylococcus aureu Strains Carrying Type II and Type IV
SCCmec Elements
Strain
SCCmec
Type
T-Cell
Survival, %
(695% CI)
Oxacillin
MIC
(lg/mL)
PBP2a Expression
(Arbitrary
Relative Units)
MRSA252 II 88 (1.4) .256 Not done
MRSA45 II 69.6 (15.4) .256 865
MRSA137 II 45 (29) .256 3830
MRSA281 II 28.6 (8.2) .256 11356
MRSA370 II 66.6 (12.8) .256 6588
MRSA504 II 69.7 (8.4) .256 1395
MRSA858 II 71.5 (7.3) .256 819
MRSA720 IV 13 (9) 32 703
90/10685 IV 0.33 (.6) 12 584
BTN170 IV 0 (0) 24 156
BTN1626 IV 2.1 (2.4) 16 127
SwedenAO IV 3.6 (2) 32 175
Abbreviations: CI, conﬁdence interval; MIC, minimum inhibitory concentration;
MRSA, methicillin-resistant Staphylococcus aureus; PBP, penicillin-binding
protein.
804 d JID 2012:205 (1 March) d Rudkin et alstrains have not been successful outside hospital settings
among healthy communities. The emergence of successful
MRSA strains infecting healthy populations with no contact
with healthcare settings (CA-MRSA) is a growing concern
[2, 4, 14] ,a n dh e r ew es h o wt h a td e s p i t et h ep r e s e n c eo f
mecA on the type IV SCCmec elements, toxicity is not af-
fected due to their lower level of PBP2a expression. This has
allowed these strains to maintain both virulence and anti-
biotic resistance and succeed where HA-MRSA could not.
In addition to mecA, another putative virulence regulatory
locus has been identiﬁed on the hospital-associated type II
SCCmec element [36], as well as a cytolytic, phenol-soluble
modulin, psm-mec [35]. Alongside our ﬁndings of the dual ac-
tivity of mecA (antibiotic resistance and virulence regulation),
this suggests that linkage between antibiotic resistance and vir-
ulence regulation has played an important role in shaping the
success of this pathogen. Future in-depth studies on the mo-
lecular interactions of these regulatory systems with those al-
ready characterized(agr,sae, rot,etc) may fundamentallychange
our understanding of virulence regulation for this important
human pathogen.
That an antibiotic resistance mechanism decreases the viru-
lence of a pathogen complicates our understanding of patho-
genicity and virulence. If we consider pathogenicity to be
environment dependent, then the HA-MRSA strains are more
pathogenic in hospitals because they can persist despite intense
antibiotic pressure. In contrast, HA-MRSA strains are less
pathogenic in the community because their impaired ability to
express toxins is not compensated for by the beneﬁts of being
antibiotic resistant. This is reﬂected in their relative success and
prevalence in these environments. Virulence, however, is in-
dependent of its environment, and in this study we show that
HA-MRSA strains are less virulent as a direct consequence of
expressing the mecA gene at high levels. This may seem an ar-
gument in semantics, but it is important to clearly understand
these differences if we are to continue to study the means by
which this pathogen causes disease in the hopes of identifying
targets for the development of novel control and treatment
strategies [42].
Notes
Acknowledgments. We would like to thank Professor Mark Enright
for providing the clinical strains.
Financial support. This work was supported by the Medical Research
Council (G0700836) and a Biotechnology and Biological Sciences Research
Council studentship.
Potential conﬂicts of interest. All authors: No reported conﬂicts.
All authors have submitted the ICMJE Form for Disclosure of Potential
Conﬂicts of Interest. Conﬂicts that the editors consider relevant to the
content of the manuscript have been disclosed.
References
1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;
339:520–32.
2. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylo-
coccus aureus infection. Clin Infect Dis 2008; 46:S350–9.
3. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-
associated meticillin-resistant Staphylococcus aureus.L a n c e t2010;
375:1557–68.
4. Ito T, Katayama Y, Hiramatsu K. Cloning and nucleotide sequence
determination of the entire mec DNA of pre-methicillin-resistant
Staphylococcus aureus N315. Antimicrob Agents Chemother 1999;
43:1449–58.
5. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of
methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;
9:486–93.
6. Hiramatsu K, Katayama Y, Yuzawa H, Ito T. Molecular genetics of
methicillin-resistant Staphylococcus aureus. Int J Med Microbiol 2002;
292:67–74.
7. Sun Y, Bauer MD, Lu W. Identiﬁcation of the active site serine of
penicillin-binding protein 2a from methicillin-resistant Staphylococcus
aureus by electrospray mass spectrometry. J Mass Spectrom 1998;
33:1009–16.
8. Schulthess B, Meier S, Homerova D, et al. Functional characterization
of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus:
role in methicillin and glycopeptide resistance. Antimicrob Agents
Chemother 2009; 53:1832–9.
9. Berger-Ba ¨chi B, Rohrer S. Factors inﬂuencing methicillin resistance in
staphylococci. Arch Microbiol 2002; 178:165–71.
10. de Lencastre H, Wu SW, Pinho MG, et al. Antibiotic resistance as
a stress response: complete sequencing of a large number of chromo-
somal loci in Staphylococcus aureus strain COL that impact on the ex-
pression of resistance to methicillin. Microb Drug Resist 1999; 5:163–75.
11. Cosgrove SE,Sakoulas G,Perencevich EN,et al.Comparisonofmortality
associated with methicillin-resistant and methicillin-susceptible Staphy-
lococcusaureusbacteremia:ameta-analysis.ClinInfectDis2003; 36:53–9.
12. Gastmeier P, Sohr D, Geffers C, et al. Mortality risk factors with nos-
ocomial Staphylococcus aureus infections in intensive care units: results
Figure 5. Expression of penicillin-binding protein 2a (PBP2a) by clinical methicillin-resistant Staphylococcus aureus (MRSA) strains carrying either
the type II or type IV SCCmec element. The relative PBP2a expression is indicated with 1, 11,o r2. The SCCmec element type is indicated as either
II or IV where relevant. Lanes 1 and 10: Molecular weight marker. Lanes 2 and 11: negative control (BH1CCDSCCmec [pRMC2]). Lanes 3 and 12: positive
control (BH1CCDSCCmec [pmecA]). Lane 4: MRSA45. Lane 5: MRSA137. Lane 6: MRSA281. Lane 7: MRSA720. Lane 8: BTN170. Lane 9: BTN1626. Lane
13: MRSA370. Lane 14: MRSA504. Lane 15: MRSA858. Lane 16: SWEDEN. Lane 17: 90/10685.
MRSA Virulence d JID 2012:205 (1 March) d 805from the German Nosocomial Infection Surveillance System (KISS).
Infection 2005; 33:50–5.
13. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among
hemodialysis-dependent patients with methicillin-resistant or
methicillin-susceptible Staphylococcus aureus bacteremia. Infect
Control Hosp Epidemiol 2005; 26:175–83.
14. Otto M. Basis of virulence in community-associated methicillin-re-
sistant Staphylococcus aureus. Annu Rev Microbiol 2010; 64:143–62.
15. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic
community-associated methicillin-resistant Staphylococcus aureus.
Proc Natl Acad Sci U S A 2009; 106:5883–8.
16. Vardakas KZ, Matthaiou DK, Falagas ME. Comparison of community-
acquired pneumonia due to methicillin-resistant and methicillin-
susceptible Staphylococcus aureus producing the Panton-Valentine
leukocidin. Int J Tuberc Lung Dis 2009; 13:1476–85.
17. Miller LG, Quan C, Shay A, et al. A prospective investigation of out-
comes after hospital discharge for endemic, community-acquired
methicillin-resistant and -susceptible Staphylococcus aureus skin in-
fection. Clin Infect Dis 2007; 44:483–92.
18. Collins J, Rudkin J, Recker M, et al. Offsetting virulence and antibiotic
resistance costs by MRSA. ISME J 2010; 4:577–84.
19. O’Neill E, Pozzi C, Houston P, et al. A novel Staphylococcus aureus
bioﬁlm phenotype mediated by the ﬁbronectin-binding proteins,
FnBPA and FnBPB. J Bacteriol 2008; 190:3835–50.
20. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev
Genet 2008; 42:541–64.
21. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. Cloning,
characterization, and sequencing of an accessory gene regulator (agr)i n
Staphylococcus aureus. J Bacteriol 1988; 170:4365–72.
22. Novick RP, Ross HF, Projan SJ, et al. Synthesis of staphylococcal
virulence factors is controlled by a regulatory RNA molecule. EMBO J
1993; 12:3967–75.
23. Novick RP. Properties of a cryptic high-frequency transducing phage in
Staphylococcus aureus. Virology 1967; 33:155–66.
24. Enright MC, Day NP, Davies CE, et al. Multilocus sequence typing
for characterization of methicillin-resistant and methicillin-
susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000;
38:1008–15.
25. Cookson BD, Robinson DA, Monk AB, et al. Evaluation of molecular
typing methods in characterizing a European collection of epidemic
methicillin-resistant Staphylococcus aureus strains: the HARMONY
collection. J Clin Microbiol 2007; 45:1830–7.
26. Price J, Baker G, Heath I, et al. Clinical and microbiological determi-
nants of outcome in Staphylococcus aureus bacteraemia. Int J Microbiol
2010: 654858.
27. Corrigan RM, Foster TJ. An improved tetracycline-inducible ex-
pression vector for Staphylococcus aureus.P l a s m i d2009; 61:126–9.
28. Bruckner R. A series of shuttle vectors for Bacillus subtilis and
Escherichia coli.G e n e1992; 122:187–92.
29. Qazi SN, Counil E, Morrissey J, et al. Agr expression precedes escape of
internalized Staphylococcus aureus from the host endosome. Infect
Immun 2001; 69:7074–82.
30. Collins J, Buckling A, Massey RC. Identiﬁcation of factors contributing
to T-cell toxicity of Staphylococcus aureus clinical isolates. J Clin
Microbiol 2008; 46:2112–4.
31. McDowell P, Affas Z, Reynolds C, et al. Structure, activity and evolu-
tion of the group I thiolactone peptide quorum-sensing system of
Staphylococcus aureus. Mol Microbiol 2001; 41:503–12.
32. Fowler VG, Sakoulas G, McIntyre LM, et al. Persistent bacteremia due
to methicillin-resistant Staphylococcus aureus infection is associated
with agr dysfunction and low-level in vitro resistance to thrombin-
induced platelet microbicidal protein. J Infect Dis 2004; 190:1140–9.
33. Recsei P, Kreiswirth B, O’Reilly M, et al. Regulation of exoprotein gene
expression in Staphylococcus aureus by agr. Mol Gen Genet 1986; 202:
58–61.
34. Haque R, Baldwin JN. Puriﬁcation and properties of staphylococcal
beta-hemolysin. J Bacteriol 1964; 88:1304–9.
35. Queck SY, Khan BA, Wang R, et al. Mobile genetic element-encoded
cytolysin connects virulence to methicillin resistance in MRSA. PLoS
Pathog 2009; 5:e1000533.
36. Kaito C, Saito Y, Nagano G, et al. Transcription and translation
products of the cytolysin gene psm-mec on the mobile genetic element
SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog 2011;
7:e1001267.
37. Traber K, Novick R. A slipped-mispairing mutation in AgrA of labo-
ratory strains and clinical isolates results in delayed activation of agr
and failure to translate delta- and alpha-haemolysins. Mol Microbiol
2006; 59:1519–30.
38. Shopsin B, Eaton C, Wasserman GA, et al. Mutations in agr do not
persist in natural populations of methicillin-resistant Staphylococcus
aureus. J Infect Dis 2010; 202:1593–9.
39. de Jonge BLM, Tomasz T. Abnormal peptidoglycan produced in
a methicillin-resistant strain of Staphylococcus aureus grown in the
presence of methicillin: functional role for penicillin-binding protein 2A
in cell wall synthesis. Antimicrob Agents Chemother 1993;3 7 : 3 4 2 – 6 .
40. de Jonge BLM, Chang YS, Gage D, Tomasz A. Peptidoglycan composi-
tion of a highly methicillin-resistant Staphylococcus aureus strain. J Biol
Chem 1992; 267:11248–64.
41. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new
methicillin-resistant Staphylococcus aureus clones in the community.
J Clin Microbiol 2002; 40:4289–94.
42. Kreiswirth BN, Lo ¨fdahl S, Betley MJ, et al. The toxic shock syndrome
exotoxin structural gene is not detectably transmitted by a prophage.
Nature 1983; 305:709–12.
806 d JID 2012:205 (1 March) d Rudkin et al